sign in sign up
<<
Home , Ketamine, Nitrous oxide

ACTA SCIENTIFIC DENTAL SCIENCES (ISSN: 2581-4893) Volume 3 Issue 10 October 2019 Opinion

Opioid Activity of Nitrous and

Mark A Gillman* Emeritus CEO South African Brain Research Instituted, South Africa *Corresponding Author: Mark A Gillman, Emeritus CEO South African Brain Research Instituted, South Africa. Received: August 30, 2019; Published: September 13, 2019 DOI: 10.31080/ASDS.2019.03.0642

I read the excellent recent paper by Eslaamisaad and Topic Of course, they are quite correct in averring that N2O interacts [1] with interest. Nonetheless, some of their statements need with other systems apart from the system [1].

These authors [1] suggested that both N – methyl – D - aspartate (NMDA) and Gamma modification. For instance, they state “Recent studies have is 50% combined with 50% in the mixture”. There are good - aminobutyric acid type A (GABA - A) receptors are affected also mention that “The dose of reasons to take issue with the routine use of a 50:50% mixture of nitrous oxide and oxygen. Rather the required effects through an antagonistic action on NMDA receptors….” by nitrous oxide” and later in the paper “Ketamine generates its of N O should be titrated to the individual requirements of each Unfortunately, there is no mention of the opioid system in the 2 patient, by employing the gentler dental titration technique, to actions of either nitrous oxide or ketamine. avoid unnecessary side effects. The side effects associated with a

There is good and abundant evidence clearly showing that the 2O and oxygen include, nausea, vomiting, endogenous opioid substances and receptors are involved in the pre - anaesthetic excitation or even actual anaesthesia [20-22]. fixed 50% mixture of N actions of both nitrous oxide (N O) and ketamine. 2 I think it is important to bring this information to the attention of your readers. participation in the actions of nitrous oxide (N O). Readers will First, let us look at the evidence for endogenous2 opioid Funding sources note that these studies have been conducted in both animals and Nil. man, conclusively showing that N2O has opioid properties [2,3]. Some of these publications indirectly implicate the endogenous Conflict of Interest opioid system in the actions of N O [4-11]. There are also radio 2 I have been researching and publishing on the psychotropic - receptor binding studies that indicate that N O acts directly on 2 properties of nitrous oxide for over 40 years. Since 2003, I have opioid receptors, in animals [12,13] and man [14]. It is also of been a medical adviser to Sedatek, a South African company that interest that N 2 supplies equipment for administering low of ni- been showed to have a role in [15,16]. It is also O, and not (NO), was the first to have trous oxide in South Africa, predominantly among dentists. I own clear from some these studies that N O is a partial opioid 2 no shares in the company. [2,3]. Bibliography Second there is also good evidence, that ketamine interacts 1. with endogenous opioid system [8,17-20]. Although more research Acta Scientific Dental Sciences 3 (2019): 40-46. needs to be done to establish whether it does so by binding directly Eslaamisaad S and Tophci S. “ in Pediatric ”. to opioid receptors (like N O) or merely by provoking the release of 2. - 2 acts with the endogenous opioid system: A review of the evi- endogenous . Gillmandence”. MA. Sciences “ 39.14 [sub (1986): anaesthetic] 1209-1221. nitrous oxide inter

Citation: Mark A Gillman. Acta Scientific Dental Sciences 3.10 (2019): 41-42.

“Opioid Activity of Nitrous Oxide and Ketamine”. Opioid Activity of Nitrous Oxide and Ketamine

42 3. 16. Nature 367 family after almost two centuries”. South African Journal of Sci- (1994): 28. enceGillman 89 (1993): MA. “Analgesic 25-27. nitrous oxide should join the opioid Gillman MA and Lichtigfeld FJ. “NO comments”. 17. Hirota K1., et al 4. Berkowitz BA., et al with recombinant mu, kappa, and delta opioid receptors ex- action”. Science 194.4268 (1976): 967-968. pressed in Chinese. “Stereoselectivehamster ovary cells”. interaction Anesthesiology of ketamine 90.1 . “Nitrous oxide analgesia: resemblance to (1999):174-182. 5. et al - kephalin and met5--arg6-phe7 into canine third 18. Sarton E1., et al Finck AD., . “Nitrous oxide Anesthesiaselectively andreleases Analgesia met5-en 80.4 in ketamine-induced respiratory depression and antinocicep- (1995): 664-670. tion”. . and“The Analgesia involvement 93.6 of (2001): the mu-opioid 1495-1500. receptor ventricular ”. 6. Quock RM., et al - 19. - tiation of nitrous oxide antinociception by in mice”. amine analgesia”. Anesthesiology 56.4 (1982): 291-297. Journal of Pharmacology. “Dose-dependent and Experimental antagonism Therapeutics and poten 267.1 Finck AD and Ngai SH. “Opiate receptor mediation of ket (1993): 117-122. 20. - tions of nitrous oxide in psychiatry”. Clinical Psychopharma- 7. Hara S., et al cologyGillman 39.4 MA. (2019): “Words 421-422. of caution on using fixed 50% concentra oxide antinociception in ”. Pharmacology Biochemistry and Behaviour 48.3. “Effect (1994) of 8: opioid 699-702. peptide antiserum on nitrous 21. Edition, St Louis: Mosby, (1989). 8. et al - Malamad SF. “Sedation: A guide to patient management”. 2nd creases the analgesic effects of ketamine and nitrous oxide in 22. - Finckmice”. Anesthesiology AD., . “Irreversible 69 (1988): opioid A604. receptor blockade de tists”. In: Eger, E.I. 11 ed, Nitrous oxide/N2O., New York: Else- vier,Smith (1985): RA and 281-304. Beirne OR. “The use of nitrous oxide by den 9. et al - kephalin and met5-enkephalin-arg6-phe7 into canine third Finck AD., . “Nitrous oxide Anesthesiaselectively andreleases Analgesia met5-en 80.4 Volume 3 Issue 10 October 2019 (1995): 664-670. © All rights are reserved Mark A Gillman. ventricular cerebrospinal fluid”. 10. Gillman MA., et al oxide analgesia in man”. European Journal of Pharmacology 61.2 (1980): 175-177.. “Paradoxical effect of naloxone on nitrous

11. sulphate and nitrous oxide on chronic states inGillman man”. MAJournal and ofLichtigfeld Neurological FJ. “A Sciences comparison 49.1 (1981): of the effects 41-45. of

12. Daras C., et al - trous oxide as an opioid agonist”. European Journal of Pharma- cology 89.1-2 .(1983): “3[H]-Naloxone 177-178. displacement: evidence for ni

13. Ori C., et al kappa opioid receptors in guinea- pig brain”. Anesthesiology 70.3 (1989):. “Effects 541-544. of nitrous oxide and on mu and

14. Van Heerden BB., et al endogenous opiate system”. Journal of Nuclear 33 (1992): 883-884. . “The effect of nitrous oxide on the

15. - sion”. British Medical Journal 305 (1992):1368. Gillman MA. “Nitrous oxide, Nitric oxide and neurotransmis

Citation: Mark A Gillman. Acta Scientific Dental Sciences 3.10 (2019): 41-42.

“Opioid Activity of Nitrous Oxide and Ketamine”.